Topline Eli Lilly, the GLP-1 maker behind Mounjaro and Zepbound, said it would file for Food and Drug Administration approval of its powerful retatrutide weight-loss drug after studies found participants lost an average of nearly 56 pounds after 80 weeks on the medication
Metabolic-bariatric surgery reduces pancreatic cancer risk: a meta-analysis of over 3.7 million adults, independent of type 2 diabetes status
These might include stress, diet, physical activity, sleep, medications, and more
Better alternatives to Peaka GLP-1 If Peaka GLP-1 is not the answer, what is
Recently, over-the-counter dietary supplements that dont require a prescription have hit the market, including Kourtney Kardashians Lemme GLP-1 Daily, which claims to naturally boost GLP-1 levels in the body to reduce hunger and support healthy weight management
CEO & Superintendent Pharmacist, iQ Doctor - Registration Number 2059792